Clinical Trials Logo

Filter by:
NCT ID: NCT06198946 Suspended - Stroke Clinical Trials

External Diaphragm Pacing Therapy and Correlation Analysis of Trunk Balance and Respiratory Function in Stroke Patients

Start date: February 13, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to observe the enhancement of trunk balance ability, pulmonary function, and diaphragm function in stroke patients after treatment of external diaphragm pacing(EDP), and analyze the potential correlation between trunk balance ability and respiratory function metrics. The main questions it aims to answer are: - What is the effect of EDP treatment on trunk balance and respiratory function in stroke patients? - Is there a correlation between trunk balance ability and respiratory function? Participants admitted to the Department of Rehabilitation Medicine at the First Affiliated Hospital of Anhui Medical University were randomly divided into an observation group and a control group: - The control group received conventional rehabilitation therapy for 4 weeks. - The observation group received EDP treatment in addition to conventional rehabilitation therapy for 4 weeks.

NCT ID: NCT06198907 Not yet recruiting - Clinical trials for Non-Small-Cell Lung Cancer

Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)

JACKPOT33
Start date: January 2024
Phase: Phase 2
Study type: Interventional

This is a phase 2 Study to investigate the safety, tolerability, and anti-tumor activity of golidocitinib in combination with sintilimab as the front-line treatment for patients with metastatic PD-L1 positive non-small cell lung cancer (NSCLC)

NCT ID: NCT06198894 Recruiting - Chronic Sinusitis Clinical Trials

Steroid-eluting Sinus Stent for Chronic Rhinosinusitis Patients With Uncontrolled Postoperative Symptoms

Start date: January 10, 2024
Phase: N/A
Study type: Interventional

Stent-001 study is a randomized controlled clinical trial with the steroid-eluting Sinus in 96 chronic rhinosinusitis patients with uncontrolled postoperative symptoms

NCT ID: NCT06198868 Recruiting - Clinical trials for Non-small Cell Lung Cancer

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

Start date: February 1, 2024
Phase:
Study type: Observational [Patient Registry]

This is a prospective cohort study, which aims to evaluate the effectiveness and superiority of a novel minimal residual disease-guided prognosis monitoring and adjuvant treatment in stage IIA-IIIC non-small cell lung cancer.

NCT ID: NCT06198790 Not yet recruiting - Anemia Clinical Trials

Postoperative Anemia After Bariatric Surgery

Start date: February 1, 2024
Phase:
Study type: Observational [Patient Registry]

To investigate the real incidence of short and long-term anemia after bariatric surgery, and explore the risk factors.

NCT ID: NCT06198777 Recruiting - Clinical trials for MCG Reference Intervals Determination for Healthy Adults

Determination of MCG Reference Intervals in Healthy Individuals

Start date: January 8, 2024
Phase:
Study type: Observational

Magnetocardiography (MCG) is a promising noninvasive and accurate method for detecting cardiac abnormalities. However, the results of MCG cannot be evaluated without defined reference intervals. This is a multicenter cross-sectional study designed to establish reference values for MCG parameters healthy adults in China.

NCT ID: NCT06198764 Recruiting - Mental Health Issue Clinical Trials

A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection

Start date: July 6, 2023
Phase: Phase 3
Study type: Interventional

A clinical study to evaluate Colistimethate Sodium for Injection combination with Meropenem versus Coly-Mycin® M Parenteral combined with Meropenem in the treatment of Carbapenem resistant gram-negative bacteria infection. A total of 80 patients will be enrolled in the study.

NCT ID: NCT06198751 Recruiting - Breast Cancer Clinical Trials

A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

Start date: February 5, 2024
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of neoadjuvant treatment with TQB2102 for injection in patients with Her2 positive breast cancer.

NCT ID: NCT06198725 Recruiting - Type 1 Diabetes Clinical Trials

Intervention for Children With Type 1 Diabetes Targeting Gut Microbes

TRIM1
Start date: January 8, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical study is to evaluate the effect of nutritional intervention program based on dietary products in the clinical treatment of newly diagnosed children with type 1 diabetes. The main question aims to answer is: whether high fiber diet can protect beta-cell function in children with newly onset type 1 diabetes. Participants will take 12 weeks of high fiber diet intervention and beta-cell function and gut microbiota structure will be analyzed.

NCT ID: NCT06198556 Completed - Clinical trials for Advanced Solid Tumor

Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects

Start date: January 14, 2024
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to evaluate the effect of rifampicin on pharmacokinetics of healthy adult subjects after oral administration of HRS-1167 tablets. The secondary objective of the study is to evaluate the safety of HRS-1167 alone and when co-administered with rifampicin.